<DOC>
	<DOCNO>NCT00317330</DOCNO>
	<brief_summary>This study test effectiveness two different tuberculosis ( TB ) prevention strategy , DOTS DOTS-A . DOTS current prevention strategy TB . DOTS-A enhance prevention strategy screen household member individual diagnose active TB provide enhance treatment need . The study conduct 8 community locate Rio de Janeiro . Study participant include 6400 male female age , include active TB patient household contact . Patients TB identify treatment Health Clinics 8 urban community eligible . The community assign 1 2 prevention strategy , DOTS DOTS-A . After 4 year , information gather study use determine incidence TB community see prevention strategy effective decreasing TB .</brief_summary>
	<brief_title>A Randomized Trial DOTS Versus Enhanced DOTS Community Control Tuberculosis</brief_title>
	<detailed_description>This single site , prospective , community-randomized trial study effectiveness two TB prevention strategy community incidence TB : DOTS versus Enhanced DOTS ( DOTS-Ampliado , DOTS-A ) . DOTS-A add intensive screen household contact active TB case provision TB treatment prophylaxis need standard DOTS regimen . Adult contact DOTS-A community offer enrollment randomized clinical trial compare rifapentine/isoniazid preventive therapy rifampin/pyrazinamide . Subjects recruit TB case identify treatment Health Clinics eight urban community . These community match randomly assign receive either DOTS DOTS-A strategy . The change incidence TB two group community measure 4-year period determine whether DOTS-A strategy significantly reduce incidence TB compare DOTS alone .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Pyrazinamide</mesh_term>
	<criteria>Cases include : 1 . Any age male female new recurrent diagnosis TB 2 . Willingness ability adhere study medication protocol procedure . 3 . Willingness provide sign informed consent sign informed consent/assent provide parent legal guardian . Contacts include : 1 . Male female living household pulmonary TB case , high risk develop TB ( without evidence active TB ) . 2 . Highrisk household contact define : HIV seropositive , regardless result initial tuberculin skin test ( TST ) TST positive time first household evaluation . TST positivity define great equal 5 mm induration 5 TU PPD use Mantoux method , read 48 72 hour application . TST negative time first household evaluation TST positive time second household evaluation 3 month later . Willingness provide sign informed consent sign informed consent/assent provide parent legal guardian . Contacts exclude preventive therapy : 1 . Current active clinical tuberculosisconfirmed suspected 2 . History sensitivity/intolerance study medication 3 . Evidence acute hepatitis 4 . History laboratory evidence cirrhosis 5 . Pregnant female ( treatment latent infection defer )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>